BWAY

Q: What is the price of BrainsWay (BWAY) today?

A cotação de BrainsWay (BWAY) hoje está em $ 16.71, com uma variação de The stock began the year trading around $ 19.02 and is currently priced at $ 16.71. negociando na casa dos $ 19.02 e hoje está em $ 16.71. Acompanhe o and track broader market trends directly on the platform.

Q: When does BrainsWay (BWAY) pay dividends?

BrainsWay (BWAY) did not pay dividends over the past year.

Q: Is BrainsWay (BWAY) a good investment?

Atualmente, BrainsWay (BWAY) está cotada a $ 16.71, com um P/L de 81.55, This represents a 2,403% premium compared to its historical average P/E. uma variação de 283.7 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 283.70%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

BrainsWay Ltd.

Price

$ 16.71

return (12m)

283.70%

p/e

81.55

p/bv

8.51

DIVIDEND YIELD

0.00%

BWAY price

BWAY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BWAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

36.30%

3 months

53.44%

1 year

283.70%

2 years

442.53%

5 years

274.24%

10 years

0.00%

Fundamentals BWAY

review the fundamentals of BrainsWay shares

P/E

81.55

Sector: -2.06 Industry: 0.33

P/S (PSR)

11.93

Sector: 1.92 Industry: 2.39

P/BV

8.51

Sector: 2.15 Industry: 2.33

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

6.77%

Sector: -26.18% Industry: -25.13%

ROE

10.43%

Sector: -30.04% Industry: -35.35%

ROIC

17.30%

Sector: -416.85% Industry: -76.64%

NET MARGIN

14.63%

Sector: -28.27% Industry: -31.46%

GROSS MARGIN

75.43%

Sector: 44.63% Industry: 50.66%

OPERATING MARGIN

8.29%

Sector: -23.33% Industry: -27.95%

EV/EBITDA

53.67

Sector: -0.50 Industry: 1.01

EV/EBIT

61.81

Sector: -1.98 Industry: -0.27

PRICE-TO-ASSETS

5.52

Sector: 1.16 Industry: 1.20

BVPS

1.98

Sector: 3.80 Industry: 4.82

EPS

0.21

Sector: -0.90 Industry: -0.85

EQUITY-TO-ASSETS RATIO

0.65

Sector: 0.44 Industry: 0.45

LIABILITIES / ASSETS

0.35

Sector: 0.47 Industry: 0.50

CAGR REVENUE 5 YEARS

11.98%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF BrainsWay ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 16.71

Fair Value

$ 0.00

Upside/Downside Return potential.

-81.70%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BWAY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	34.11	27.64	81.01%	0.65%	$ 862.18 B	34.98%
ISRG	54.55	9.24	16.93%	0.00%	$ 162.51 B	28.15%
TMO	25.49	3.35	13.15%	0.38%	$ 174.55 B	15.15%
SNY	12.33	1.34	10.86%	4.80%	$ 112.48 B	18.68%
NVS	20.68	7.19	34.77%	2.12%	$ 279.88 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	22.25	2.09	9.38%	3.55%	$ 102.64 B	13.00%
GSK	13.24	4.47	33.77%	3.40%	$ 103.84 B	17.79%
CVS	58.97	1.38	2.35%	3.24%	$ 104.25 B	0.44%
BSX	23.54	0.00	0.00%	0.00%	$ 83.90 B	17.29%
TMDX	17.87	7.19	40.22%	0.00%	$ 3.40 B	31.43%
HCA	14.28	-32.58	-228.14%	0.68%	$ 97.01 B	8.89%
IDXX	42.85	28.28	65.99%	0.00%	$ 45.40 B	24.62%
RMD	19.56	4.58	23.41%	1.14%	$ 29.73 B	27.44%
DHR	33.62	2.34	6.97%	0.78%	$ 124.01 B	14.89%
INMD	9.68	1.33	13.73%	0.00%	$ 907.83 M	25.32%
PHG	23.98	1.93	8.06%	3.39%	$ 24.88 B	5.07%
SYK	34.78	5.03	14.48%	1.17%	$ 112.88 B	12.92%
FMS	11.40	0.77	6.75%	3.50%	$ 12.86 B	5.02%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

BWAY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BrainsWay

BrainsWay Ltd.

Average Investor10 user rating

4.0 (3 people)

United States

20 years

Founded: 2006

2019

Time since IPO - 7 years

100

Employees

BrainsWay Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $623.08 Millions, with shareholders equity totaling $73.22 Millions.

The company employs approximately 100 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, BrainsWay Ltd. reported $52.22 Millions in revenue, generating net income of $7.64 Millions.

Key financial metrics include a P/E ratio of 81.55, a price-to-book (P/B) ratio of 8.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BWAY.

Market cap

$ 623.08 Millions

Net worth

$ 73.22 Millions

$ 73,220,000.00

Assets

$ 112.92 Millions

$ 112,920,000.00

Total Shares Outstanding

37.00 Millions

37,000,000

Average Daily Trading Volume

$ 165.25 Thousand

$ 165,248.82

Sector

Health

Industry

Medical Supplies and Equipment

BWAY

BWAY revenue and profits

Financial Results BWAY

DRAG THE FRAME TO SEE MORE DATA

BWAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 87.36 33,46% (12M)

P/E

58.97

3.24%

ROE

2.35%

P/BV

1.38

CI - Cigna

$ 284.04 --12,44% (12M)

P/E

10.33

2.15%

ROE

16.97%

P/BV

1.75

CNC - Centene

$ 54.98 --11,92% (12M)

P/E

-4.07

0.00%

ROE

-29.93%

P/BV

1.22

HUM - Humana

$ 247.12 --0,51% (12M)

P/E

24.81

1.52%

ROE

6.06%

P/BV

1.50

LLY - Eli Lilly

$ 974.96 33,69% (12M)

P/E

34.11

0.65%

ROE

81.01%

P/BV

27.64

HCA - HCA Healthcare

$ 429.02 22,25% (12M)

P/E

14.28

0.68%

ROE

-228.14%

P/BV

-32.58

NVS - Novartis

$ 145.36 34,57% (12M)

P/E

20.68

2.12%

ROE

34.77%

P/BV

7.19